BIOCRYST PHARMACEUTICALS, INC. Weighted Average Number of Shares Outstanding, Basic and Diluted (Deprecated 2012-01-31)
BIOCRYST PHARMACEUTICALS, INC. (BCRX) had Weighted Average Number of Shares Outstanding, Basic and Diluted (Deprecated 2012-01-31) of 47.10 million shares as of 2012-03-31, per its 10-Q filed 2012-05-08.
Discontinued › Notes
us-gaap:WeightedAverageNumberOfSharesOutstandingBasicAndDiluted · last filed 2012-05-08
- 2012-03-31: Weighted Average Number of Shares Outstanding, Basic and Diluted (Deprecated 2012-01-31) 47.10M shares.
- 2011-12-31: Weighted Average Number of Shares Outstanding, Basic and Diluted (Deprecated 2012-01-31) 45.14K shares.
- 2011-03-31: Weighted Average Number of Shares Outstanding, Basic and Diluted (Deprecated 2012-01-31) 44.99M shares.
- 2010-12-31: Weighted Average Number of Shares Outstanding, Basic and Diluted (Deprecated 2012-01-31) 44.56K shares.
| Period end | Weighted Average Number of Shares Outstanding, Basic and Diluted (Deprecated 2012-01-31) |
|---|---|
| 2012-03-31 | 47.10M shares 10-Q · filed 2012-05-08 |
| 2011-12-31 | 45.14K shares 10-K · filed 2012-03-06 |
| 2011-03-31 | 44.99M shares 10-Q · filed 2012-05-08 |
| 2010-12-31 | 44.56K shares 10-K · filed 2012-03-06 |
| 2009-12-31 | 38.93K shares 10-K · filed 2012-03-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ADMA BIOLOGICS, INC. (ADMA) | United States | $2.131B | 11.16 |
| Kodiak Sciences Inc. (KOD) | United States | $2.090B | -10.12 |
| RECURSION PHARMACEUTICALS, INC. (RXRX) | United States | $2.080B | -3.78 |
| Vericel Corp (VCEL) | United States | $2.011B | 93.97 |
| Greenland Mines Ltd (GRML) | United States | $2.362B | |
| Vir Biotechnology, Inc. (VIR) | United States | $1.814B | -6.85 |
| Beam Therapeutics Inc. (BEAM) | United States | $2.549B | -41.51 |
| NOVAVAX INC (NVAX) | United States | $1.748B | -6.26 |
| Hemab Therapeutics Holdings, Inc. (COAG) | United States | $1.672B | |
| Immunocore Holdings plc (IMCR) | $1.613B | -90.43 |